Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

3 Biotech Stocks to Buy Instead of Palatin Technologies (PTN)

While Palatin Technologies (PTN) has faced challenges with declining share price, negative analyst projections, and limited profitability, it's worth noting the consistent growth in the broader biotech industry. Thus, investors could find more stable returns in robust biotech stocks Protalix BioTherapeutics (PLX), Exelixis (EXEL), and Jazz Pharmaceuticals (JAZZ) instead. Read…

StockNews.com

3 A-Rated Pharma Buys for October

The growing adoption of innovative drugs and the heightened demand for personalized medicines are expected to boost the pharma industry. Therefore, it might be wise to buy fundamentally strong pharma stocks Neurocrine Biosciences (NBIX), Novo Nordisk (NVO), and AstraZeneca PLC (AZN), which are rated an A (Strong Buy) in our…

StockNews.com

‘My posts are backed up with solid evidence, research’: Liver Doc on Himalaya Wellness suit

“Based on strong scientific evidence, or because of lack of it, I have been critical of several of Himalaya Wellness’ products,” said doctor-influencer Cyriac Abby Philips aka The Liver Doc, whose X account was suspended today for posting “defamatory remarks” against the ayurvedic pharma company.

Newslaundry

From analysis to the latest developments in health,
read the most diverse news in one place.

People with HIV offered hope of self-injected drug at home

GSK-controlled company works on developing patient-administered treatment by end of the decade

The Guardian - UK

Common children’s antibiotic amoxicillin still in short supply for the second year

While pharmacies say they can still fill most prescriptions for amoxicillin, the most-prescribed drug in the country, the shortage could worsen when the viral season hits this winter, experts say.

Chicago Sun-Times

New York drug consumption rooms to influence Glasgow pilot, First Minister says

GLASGOW’S pioneering drug consumption room will be shaped by research carried out in New York City, the First Minister has said.

The National (Scotland)

'Easier access': Oral contraceptives from pharmacies

'Recognition of the capabilities that pharmacies have.'

Newcastle Herald

Read news from The Economist, FT, and more,
with one subscription

The first OTC birth control is coming

An OTC birth control pill will help ensure more people can access the contraception they need without barriers

Salon

An overdose drug is finally over-the-counter. Is that enough to stop the death toll?

Narcan is now available in drug stores without a prescription. The nasal spray can save a life by stopping an opioid overdose. But will people pay the price and ask for it by name?

WEKU

Prescription pilot just the tonic for pharmacists

Pharmacists will be able to prescribe medications and administer more vaccines under a pilot program being expanded throughout Queensland.

AAP

Draft patent amendment rules undermine pre-grant opposition

Draft patent rules threaten pre-grant opposition, a key public health safeguard. Big pharma seeks to remove essential safeguards from India’s patent laws, creating needless hurdles in pre-grant opposition. Draft rules introduce variable fees, power to determine maintainability of representation by individuals/groups. This threatens access to quality-assured, affordable generics & extends…

The Hindu

Bionano Genomics (BNGO) Challengers: 3 Biotech Innovators to Buy Instead

With the rising aging population and the emergence of new diseases, the biotech industry appears poised for steady growth. Therefore, three quality biotech stocks, Vanda Pharmaceuticals (VNDA), Organogenesis Holdings (ORGO), and Exelixis (EXEL), could be better catches than Bionano Genomics (BNGO). Read on….

StockNews.com

Walgreens and CVS warned about selling illegal eye products

Warning letters sent to the companies claimed certain products they sell are ‘especially concerning from a public health perspective’

The Independent UK

Revolving door redux: The DEA's recently departed No. 2 returns to a Big Pharma consulting firm

Washington’s revolving door kept spinning this week as the Drug Enforcement Administration’s recently departed second-in-command returned for another stint with a high-powered consulting firm where he previously advised OxyContin maker Purdue Pharma

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Newsroom.co.nz

Workplace drug testing quagmire deepens

Medical cannabis is behind an uptick in workplace drug detection and the solution isn't clear-cut, reports Andrew Bevin

The Hindu

Xpert MTB/RIF molecular test for tuberculosis diagnosis to cost 20% less

Danaher Corporation, which sells the Xpert MTB/RIF molecular test for diagnosing tuberculosis (TB) and rifampicin resistance, has announced a lowering of the price of its standard TB test cartridge

StockNews.com

3 Biotechs with Massive Growth Potential

These three biotech stocks have massive growth opportunities on the horizon, and could add a huge boost to any portfolio. They play in some of the most in demand markets on the planet, and have track records of finding ways to introduce products into those markets to capture big profits.…

The National (Scotland)

Three Scottish cities to apply for drug testing facilities, says minister

APPLICATIONS will be made for drug testing facilities in three Scottish cities, drugs policy minister Elena Whitham has said...

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Is Palatin Technologies (PTN) Stock a Biotech Buy Before Earnings?

Palatin Technologies’ (PTN) stock has plummeted more than 75% over the past year. Since its inception, the biotech company has incurred massive net losses and negative cash flows from operations. Further, it anticipates incurring additional losses in the future. So, let’s determine if PTN is a buy or sell before…

The Independent UK

Expand pharmacy capabilities to ease pressure on GPs, think tanks say

The report outlined a number of recommendations for policymakers, as well as ‘significant’ barriers facing the sector.

StockNews.com

3 Healthcare Stocks to Buy Today

The POWR Ratings system points the way to 3 of the most attractive healthcare stocks on the market today. Read on below for why you should consider adding these 3 stocks to your portfolio: Johnson & Johnson (JNJ), Amgen (AMGN) and AbbVie (ABBV).

The National (Scotland)

Date set for Glasgow drug consumption room crunch talks

A KEY meeting to determine how the UK’s first safe drug consumption room could be trialled in Glasgow will go ahead before the end of this month,…

The Hindu

Businessline Millets Conclave: Krishna Ella calls for GST waiver for millets

StockNews.com

Which of these 3 Pharma Stocks Should You Buy, Hold or Sell?

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. So, let's analyze whether Johnson & Johnson (JNJ), Calliditas Therapeutics AB (CALT), and Aurora Cannabis (ACB) are a Buy, Hold, or Sell.

The Independent UK

Big Pharma's Johnson & Johnson under investigation in South Africa over 'excessive' drug prices

U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug

1 … 44 45 46 47

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Scottish Government

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.